Aurora Gomez-Duran

8PUBLICATIONS
42CO-AUTHORS
Molecular targetsLife historiesMedical infection agents (incl. prions)Metabolic medicineEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions.

|Mar 06, 2025
Cryptic mitochondrial DNA mutations coincide with mid-late life and are pathophysiologically informative in single cells across tissues and species.

Alistair P Green, Florian Klimm, Aidan S Marshall

|Feb 19, 2024
Author Correction: Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging.

Juan Ignacio Jiménez-Loygorri, Beatriz Villarejo-Zori, Álvaro Viedma-Poyatos

|Jan 27, 2024
Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging.

Juan Ignacio Jiménez-Loygorri, Beatriz Villarejo-Zori, Álvaro Viedma-Poyatos

|Feb 29, 2020
Metabolic effects of bezafibrate in mitochondrial disease.

Hannah Steele, Aurora Gomez-Duran, Angela Pyle

|Jul 25, 2019
Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila.

Simonetta Andreazza, Colby L Samstag, Alvaro Sanchez-Martinez

Pageof 2

Frequent Collaborators

3 joint publications

Patrick F Chinnery

2 joint publications

Juan Carlos Espín

2 joint publications

Francisco A Tomás-Barberán

2 joint publications

Patricia Boya